#BEGIN_DRUGCARD DB01694

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
147-71-7

# ChEBI_ID:
15672

# Chemical_Formula:
C4H6O6

# Chemical_IUPAC_Name:
(2R,3S)-2,3-dihydroxybutanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
1E+006 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
D-tartaric acid

# HET_ID:
TAR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2+

# InChI_Key:
InChIKey=FEWJPZIEWOKRBE-XIXRPRMCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C02107

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1694

# Mechanism_Of_Action:
Not Available

# Melting_Point:
172.5 °C

# Molecular_Weight_Avg:
150.0868

# Molecular_Weight_Mono:
150.016437924

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1RQW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
0.03

# Predicted_Water_Solubility:
1.61e+02 g/l

# Primary_Accession_No:
DB01694

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
447315

# PubChem_Substance_ID:
46508249

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03007

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H]([C@@H](O)C(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
(-)-Tartaric acid
(2S,3S)-Tartaric acid
(S,S)-Tartaric acid
(S,S)-Tartrate
D-Tartrate
D-threaric acid
Levotartaric Acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:24 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Tartaric_acid

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AE004091

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
rmlC

# Drug_Target_10_Gene_Sequence:
>546 bp
ATGAAAGCGACCCGCCTGGCAATTCCCGACGTCATCCTCTTCGAACCCCGGGTGTTCGGC
GACGATCGCGGATTCTTCTTCGAAAGCTACAACCAGCGCGCCTTCGAGGAAGCCTGCGGT
CATCCGGTCAGCTTCGTCCAGGACAACCATTCGCGTTCCGCCCGTGGCGTCCTCCGCGGC
CTGCACTACCAGATCCGGCAAGCCCAGGGAAAACTGGTGCGCGCCACTCTCGGCGAGGTA
TTCGACGTGGCCGTCGACCTGCGTCGCGGCTCGCCGACCTTCGGCCAGTGGGTAGGCGAA
CGCCTGAGCGCGGAGAACAAGCGCCAGATGTGGATTCCGGCCGGCTTCGCGCACGGCTTC
GTGGTGCTCAGCGAATACGCCGAGTTCCTCTACAAGACCACCGACTTCTGGGCGCCGGAA
CACGAACGCTGCATCGTCTGGAACGATCCCGAGCTGAAGATCGACTGGCCGCTGCAGGAT
GCCCCCCTGCTTTCGGAGAAGGACCGCCAGGGCAAGGCATTCGCCGACGCCGACTGCTTC
CCCTGA

# Drug_Target_10_General_Function:
Involved in dTDP-4-dehydrorhamnose 3,5-epimerase activity

# Drug_Target_10_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
4294

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
20767

# Drug_Target_10_Name:
DTDP-4-dehydrorhamnose 3,5-epimerase

# Drug_Target_10_Number_of_Residues:
181

# Drug_Target_10_PDB_ID:
1RTV

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00908	dTDP_sugar_isom

# Drug_Target_10_Protein_Sequence:
>DTDP-4-dehydrorhamnose 3,5-epimerase
MKATRLAIPDVILFEPRVFGDDRGFFFESYNQRAFEEACGHPVSFVQDNHSRSARGVLRG
LHYQIRQAQGKLVRATLGEVFDVAVDLRRGSPTFGQWVGERLSAENKRQMWIPAGFAHGF
VVLSEYAEFLYKTTDFWAPEHERCIVWNDPELKIDWPLQDAPLLSEKDRQGKAFADADCF
P

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
dTDP-4-dehydro-6-deoxy-D-glucose = dTDP-4- dehydro-6-deoxy-L-mannose

# Drug_Target_10_SwissProt_ID:
Q9HU21

# Drug_Target_10_SwissProt_Name:
RMLC_PSEAE

# Drug_Target_10_Synonyms:
DTDP-4-keto-6-deoxy-D-glucose 3,5 epimerase

# Drug_Target_10_Theoretical_pI:
6.02

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
AE004112

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
VC_0232

# Drug_Target_11_Gene_Sequence:
>381 bp
TTAGGAACATGATTTTTCCTTCTCAAAGAGTTGGTGGATCTCTTCTAAATTCATCGAGGC
AAATTCGGAAGGGCGCACGGCGCGATCATCAATGTAAAAGCCATCGTGCCCACACCAAGG
TTTTCCTACTAAAATTTCATCATAAGGCACTTGGTGTTTATCCAGCCACTCAGTAATGAT
AGGAAGCGTGTGGATATTGATTTTGCCGACGTTACCTTCATAAGTGCGCATATTACGCGC
CGTCGAAATCACAATCTCAAACCCTAGTTGGTGATATTCGCGAAGTTGCTCAATCACATC
AAGCCGAGGTAGCACGTTACGATAATCTGAAGTATTAGCTTGGGTGAGAGTGCCGTCGAG
GTCGACGATCAATTTTTTCAT

# Drug_Target_11_General_Function:
Not Available

# Drug_Target_11_General_References:
10952301	Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM: DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 2000 Aug 3;406(6795):477-83.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4295

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
14648

# Drug_Target_11_Name:
Hypothetical protein VC0232

# Drug_Target_11_Number_of_Residues:
126

# Drug_Target_11_PDB_ID:
1XPJ

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF08282	Hydrolase_3

# Drug_Target_11_Protein_Sequence:
>Hypothetical protein VC0232
MKKLIVDLDGTLTQANTSDYRNVLPRLDVIEQLREYHQLGFEIVISTARNMRTYEGNVGK
INIHTLPIITEWLDKHQVPYDEILVGKPWCGHDGFYIDDRAVRPSEFASMNLEEIHQLFE
KEKSCS

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Not Available

# Drug_Target_11_SwissProt_ID:
Q9KVB4

# Drug_Target_11_SwissProt_Name:
Q9KVB4_VIBCH

# Drug_Target_11_Synonyms:
Not Available

# Drug_Target_11_Theoretical_pI:
5.21

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Cytoplasmic

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
L49465

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
phnA

# Drug_Target_12_Gene_Sequence:
>1224 bp
ATGACACAACTTATCAGCGTGAACTCGCGCTCCTATCGCCTGTCGTCGGCACCGACGATT
GTTATCTGCGTCGACGGATGCGAGCAGGAATACATCAATCAAGCCATTCAAGCCGGACAG
GCACCGTTTCTCGCCGAACTTACCGGCTTCGGCACAGTGTTGACTGGCGATTGCGTGGTG
CCTTCGTTCACCAACCCGAACAATCTGTCGATCGTTACCGGGGCCCCGCCATCCGTTCAC
GGTATTTGCGGCAACTTCTTTTTTGACCAGGAGACGCAAGAGGAGGTGTTGATGAACGAC
GCGAAGTACCTTCGCGCGCCGACTATTCTTGCCGAGATGGCCAAAGCGGGCCAGCTCGTC
GCCGTGGTGACCGCAAAGGACAAGTTGCGCAACTTGCTGGGGCATCAACTGAAAGGGATC
TGTTTTTCCGCTGAAAAAGCCGACCAGGTGAATCTGGAGGAACACGGTGTCGAGAACATC
CTGGCAAGAGTCGGCATGCCCGTGCCTTCGGTATACAGCGCAGACCTTTCCGAGTTCGTG
TTTGCCGCCGGCCTCTCGTTGTTGACCAACGAACGCCCCGACTTCATGTACCTGTCCACT
ACCGATTATGTACAACACAAACATGCGCCAGGCACACCCGAAGCCAATGCGTTCTACGCA
ATGATGGACAGCTACTTCAAGCGTTATCACGAGCAAGGCGCGATCGTGGCGATTACGGCG
GATCACGGCATGAATGCCAAGACCGATGCGATAGGTCGCCCCAACATCCTGTTTTTGCAA
GACCTTCTCGATGCCCAATATGGCGCGCAGCGCACACGGGTATTACTGCCGATCACCGAC
CCTTACGTAGTGCATCACGGCGCGCTGGGCTCTTACGCGACCGTGTACTTGCGCGATGCG
GTACCGCAGCGCGATGCCATCGACTTTCTCGCAGGCATCGCCGGTGTCGAGGCAGTCTTG
ACGCGTTCGCAGGCCTGCCAGCGATTCGAACTGCCCGAAGACCGGATTGGCGACCTGGTG
GTACTCGGGGAACGACTGACGGTGCTTGGCAGTGCTGCCGACAAACACGACCTGTCCGGA
CTGACGGTGCCCTTGCGTTCCCACGGTGGTGTATCGGAGCAGAAAGTGCCACTGATCTTC
AACCGCAAGCTGGTCGGTCTCGACAGCCCCGGCCGACTGCGAAATTTCGACATTATCGAT
CTCGCGCTCAACCATCTCGCTTAA

# Drug_Target_12_General_Function:
Involved in catalytic activity

# Drug_Target_12_General_References:
11344133	Kulakova AN, Kulakov LA, Akulenko NV, Ksenzenko VN, Hamilton JT, Quinn JP: Structural and functional analysis of the phosphonoacetate hydrolase (phnA) gene region in Pseudomonas fluorescens 23F. J Bacteriol. 2001 Jun;183(11):3268-75.
9300819	Kulakova AN, Kulakov LA, Quinn JP: Cloning of the phosphonoacetate hydrolase gene from Pseudomonas fluorescens 23F encoding a new type of carbon-phosphorus bond cleaving enzyme and its expression in Escherichia coli and Pseudomonas putida. Gene. 1997 Aug 11;195(1):49-53.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
4296

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
44240

# Drug_Target_12_Name:
Phosphonoacetate hydrolase

# Drug_Target_12_Number_of_Residues:
407

# Drug_Target_12_PDB_ID:
1EI6

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF01663	Phosphodiest

# Drug_Target_12_Protein_Sequence:
>Phosphonoacetate hydrolase
MTQLISVNSRSYRLSSAPTIVICVDGCEQEYINQAIQAGQAPFLAELTGFGTVLTGDCVV
PSFTNPNNLSIVTGAPPSVHGICGNFFFDQETQEEVLMNDAKYLRAPTILAEMAKAGQLV
AVVTAKDKLRNLLGHQLKGICFSAEKADQVNLEEHGVENILARVGMPVPSVYSADLSEFV
FAAGLSLLTNERPDFMYLSTTDYVQHKHAPGTPEANAFYAMMDSYFKRYHEQGAIVAITA
DHGMNAKTDAIGRPNILFLQDLLDAQYGAQRTRVLLPITDPYVVHHGALGSYATVYLRDA
VPQRDAIDFLAGIAGVEAVLTRSQACQRFELPEDRIGDLVVLGERLTVLGSAADKHDLSG
LTVPLRSHGGVSEQKVPLIFNRKLVGLDSPGRLRNFDIIDLALNHLA

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Not Available

# Drug_Target_12_SwissProt_ID:
Q51782

# Drug_Target_12_SwissProt_Name:
PHNHY_PSEFL

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
5.37

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AE005672

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
SP_1951

# Drug_Target_13_Gene_Sequence:
>705 bp
ATGAATAAAATATTTATATATGCAGGAGTGCGAAATCATAACTCTAAGACTTTAGAGTAT
ACTAAGAGACTTTCAAGTATCATTTCTAGTAGAAATAATGTTGATATATCTTTCAGGACA
CCTTTCAATTCAGAGCTAGAAATATCTAATTCTGATTCAGAAGAGTTGTTTAAGAAAGGA
ATTGATAGGCAAAGTAATGCTGATGATGGAGGTGTTATAAAAAAAGAGTTATTAGAGTCT
GATATTATAATTATCTCTTCTCCTGTATATTTACAAAACGTATCTGTGGACACAAAAAAC
TTTATTGAAAGGATTGGGGGGTGGAGCCATCTTTTTCGATTAGCTGGAAAGTTTGTTGTA
ACATTAGATGTTGCTGAGAGTAACGGCTCTGATAATGTGTCAGAATATCTTAGAGATATA
TTTTCATATATGGGAGGACAGATATTACACCAAGTTTCAATTACCAATTCACTCAAAGAT
ATTGCAGAGGCTCAGTTGATGGAGGCAACTTATAAAATTGAAGATGTACTTGAAGGGAAA
ATTAAGTACAAAACAACGGATTATCAAGAAAGAGCTTACCAGACATTAAAATTAATTTTA
GAAAATTATGATTCCGAACATTTTGAGAAGATGTATTGGGAGAAAAAACGCCTTTTTGAA
GCTAATAGTTTAGAGGAATGGTATTATGTTGAAAATATTAAATAA

# Drug_Target_13_General_Function:
Not Available

# Drug_Target_13_General_References:
11463916	Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM: Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001 Jul 20;293(5529):498-506.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
4297

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
27148

# Drug_Target_13_Name:
Hypothetical protein

# Drug_Target_13_Number_of_Residues:
234

# Drug_Target_13_PDB_ID:
1SQS

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
Not Available

# Drug_Target_13_Protein_Sequence:
>Hypothetical protein
MNKIFIYAGVRNHNSKTLEYTKRLSSIISSRNNVDISFRTPFNSELEISNSDSEELFKKG
IDRQSNADDGGVIKKELLESDIIIISSPVYLQNVSVDTKNFIERIGGWSHLFRLAGKFVV
TLDVAESNGSDNVSEYLRDIFSYMGGQILHQVSITNSLKDIAEAQLMEATYKIEDVLEGK
IKYKTTDYQERAYQTLKLILENYDSEHFEKMYWEKKRLFEANSLEEWYYVENIK

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Not Available

# Drug_Target_13_SwissProt_ID:
Q97NR6

# Drug_Target_13_SwissProt_Name:
Q97NR6_STRPN

# Drug_Target_13_Synonyms:
Not Available

# Drug_Target_13_Theoretical_pI:
4.94

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U00039

# Drug_Target_1_GenBank_ID_Protein:
466713

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dlgD

# Drug_Target_1_Gene_Sequence:
>999 bp
ATGAAAGTGACATTTGAGCAGTTAAAAGCAGCCTTTAATCGGGTCTTAATTTCACGCGGC
GTTGACAGCGAAACGGCTGACGCCTGTGCAGAGATGTTCGCCCGCACCACCGAATCCGGC
GTTTATTCTCACGGCGTTAATCGTTTCCCTCGTTTCATTCAACAACTGGAAAACGGCGAT
ATCATTCCTGATGCCCAACCCAAACGTATAACCAGCCTCGGCGCAATTGAACAGTGGGAC
GCCCAGCGTTCGATCGGTAACCTGACAGCGAAAAAGATGATGGATCGCGCCATTGAACTG
GCTGCCGATCACGGTATTGGTCTGGTGGCACTACGTAATGCCAACCACTGGATGCGCGGC
GGCAGNTACGGCTGGCAGGCGGCGGAAAAAGGCTATATTGGCATTTGCTGGACCAACTCC
ATCGCCGTAATGCCGCCGTGGGGCGCAAAAGAGTGTCGCATAGGCACTAACCCGCTGATC
GTCGCCATTCCTTCCACGCCGATCACCATGGTCGATATGTCGATGTCGATGTTCTCTTAC
GGCATGTTAGAAGTTAACCGTCTGGCAGGTCGTCAGCTCCCGGTCGATGGTGGCTTTGAT
GATGAGGGCAATTTGACCAAAGAACCTGGCGTTATCGAGAAGAATCGCCGCATTTTGCCG
ATGGGCTACTGGAAAGGTTCTGGCATGTCGATTGTGCTGGATATGATCGCTACTCTCCTT
TCCGACGGCGCATCCGTTGCCGAAGTCACCCAGGACAACAGCGACGAATACGGCATTTCA
CAAATTTTTATTGCCATTGAAGTGGACAAGCTTATCGACGGTCCCACCCGCGATGCCAAG
CTGCAACGCATCATGGATTACGTTACTAGTGCCGAGCGTGCTGACGAAAATCAGGCCATT
CGCTTACCCGGCCATGAATTTACTACCCTGCTGGCCGAAAACCGCCGTAACGGCATCACT
GTTGATGACAGCGTGTGGGCCAAAATCCAGGCGTTATGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
11741871	Yew WS, Gerlt JA: Utilization of L-ascorbate by Escherichia coli K-12: assignments of functions to products of the yjf-sga and yia-sgb operons. J Bacteriol. 2002 Jan;184(1):302-6.
8041620	Sofia HJ, Burland V, Daniels DL, Plunkett G 3rd, Blattner FR: Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes. Nucleic Acids Res. 1994 Jul 11;22(13):2576-86.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9525947	Badia J, Ibanez E, Sabate M, Baldoma L, Aguilar J: A rare 920-kilobase chromosomal inversion mediated by IS1 transposition causes constitutive expression of the yiaK-S operon for carbohydrate utilization in Escherichia coli. J Biol Chem. 1998 Apr 3;273(14):8376-81.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2336

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
36573

# Drug_Target_1_Name:
2,3-diketo-L-gulonate reductase

# Drug_Target_1_Number_of_Residues:
332

# Drug_Target_1_PDB_ID:
1S20

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02615	Ldh_2

# Drug_Target_1_Protein_Sequence:
>2,3-diketo-L-gulonate reductase
MKVTFEQLKAAFNRVLISRGVDSETADACAEMFARTTESGVYSHGVNRFPRFIQQLENGD
IIPDAQPKRITSLGAIEQWDAQRSIGNLTAKKMMDRAIELAADHGIGLVALRNANHWMRG
GSYGWQAAEKGYIGICWTNSIAVMPPWGAKECRIGTNPLIVAIPSTPITMVDMSMSMFSY
GMLEVNRLAGRQLPVDGGFDDEGNLTKEPGVIEKNRRILPMGYWKGSGMSIVLDMIATLL
SDGASVAEVTQDNSDEYGISQIFIAIEVDKLIDGPTRDAKLQRIMDYVTSAERADENQAI
RLPGHEFTTLLAENRRNGITVDDSVWAKIQAL

# Drug_Target_1_Reaction:
3-dehydro-L-gulonate + NAD(P)+ = (4R,5S)-4,5,6-trihydroxy-2,3-dioxohexanoate + NAD(P)H + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the reduction of 2,3-diketo-L-gulonate in the presence of NADH, to form 3-keto-L-gulonate

# Drug_Target_1_SwissProt_ID:
P37672

# Drug_Target_1_SwissProt_Name:
DLGD_ECOLI

# Drug_Target_1_Synonyms:
2,3-DKG reductase
3- dehydro-L-gulonate 2-dehydrogenase
EC 1.1.1.130

# Drug_Target_1_Theoretical_pI:
4.97

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Golgi apparatus
Golgi apparatus membrane
single-pass type II membrane protein

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
B3GAT1

# Drug_Target_2_GenBank_ID_Gene:
AB029396

# Drug_Target_2_GenBank_ID_Protein:
8051678

# Drug_Target_2_GeneCard_ID:
B3GAT1

# Drug_Target_2_Gene_Name:
B3GAT1

# Drug_Target_2_Gene_Sequence:
>1005 bp
ATGCCGAAGAGACGGGACATCCTAGCGATCGTCCTCATCGTGCTGCCCTGGACTCTGCTC
ATCACTGTCTGGCACCAGAGCACCCTCGCACCCCTGCTCGCGGTACATAAGGATGAGGGC
AGTGACCCCCGACGCGAAACGCCGCCCGGCGCCGACCCCAGGGAGTACTGCACGTCTGAC
CGCGACATCGTGGAGGTGGTGCGCACCGAGTACGTGTACACGCGGCCCCCGCCATGGTCC
GACACGCTGCCCACCATCCACGTGGTGACGCCCACCTACAGCCGCCCGGTGCAGAAGGCC
GAGCTGACGCGCATGGCCAACACGCTGCTGCACGTGCCCAACCTCCACTGGCTGGTGGTG
GAGGATGCGCCGCGCCGGACGCCGCTGACCGCGCGCCTGCTGCGCGACACCGGCCTCAAC
TACACGCACCTGCACGTGGAGACGCCCCGCAACTACAAGCTGCGCGGAGACGCCCGCGAC
CCACGCATCCCGCGGGGCACCATGCAGCGCAACCTGGCCCTGCGCTGGCTGCGCGAGACC
TTCCCGCGCAACTCCAGCCAGCCTGGCGTGGTCTACTTCGCCGACGACGACAACACCTAC
AGCCTGGAGCTCTTCGAAGAGATGCGCAGCACCAGGAGGGTGTCCGTGTGGCCCGTCGCC
TTCGTGGGTGGCCTGCGGTACGAGGCCCCACGGGTGAACGGGGCAGGGAAGGTGGTCCGC
TGGAAGACGGTGTTTGACCCCCACCGGCCATTTGCAATAGACATGGCTGGATTTGCCGTC
AACCTGCGGCTCATTCTGCAGCGAAGCCAGGCCTACTTCAAGCTGCGAGGTGTGAAGGGA
GGCTACCAGGAAAGCAGCCTCCTTCGAGAACTTGTCACCCTCAACGACCTGGAGCCCAAG
GCAGCCAACTGCACCAAGATCCTGGTGTGGCACACACGGACAGAGAAGCCAGTGCTGGTG
AATGAGGGCAAGAAGGGCTTCACTGACCCCTCGGTGGAGATCTGA

# Drug_Target_2_General_Function:
Involved in galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity

# Drug_Target_2_General_References:
10783264	Mitsumoto Y, Oka S, Sakuma H, Inazawa J, Kawasaki T: Cloning and chromosomal mapping of human glucuronyltransferase involved in biosynthesis of the HNK-1 carbohydrate epitope. Genomics. 2000 Apr 15;65(2):166-73.

# Drug_Target_2_HGNC_ID:
HGNC:921

# Drug_Target_2_HPRD_ID:
06969

# Drug_Target_2_ID:
2291

# Drug_Target_2_Locus:
11q25

# Drug_Target_2_Molecular_Weight:
38356

# Drug_Target_2_Name:
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1

# Drug_Target_2_Number_of_Residues:
334

# Drug_Target_2_PDB_ID:
1V84

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF03360	Glyco_transf_43

# Drug_Target_2_Protein_Sequence:
>Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1
MPKRRDILAIVLIVLPWTLLITVWHQSTLAPLLAVHKDEGSDPRRETPPGADPREYCTSD
RDIVEVVRTEYVYTRPPPWSDTLPTIHVVTPTYSRPVQKAELTRMANTLLHVPNLHWLVV
EDAPRRTPLTARLLRDTGLNYTHLHVETPRNYKLRGDARDPRIPRGTMQRNLALRWLRET
FPRNSSQPGVVYFADDDNTYSLELFEEMRSTRRVSVWPVAFVGGLRYEAPRVNGAGKVVR
WKTVFDPHRPFAIDMAGFAVNLRLILQRSQAYFKLRGVKGGYQESSLLRELVTLNDLEPK
AANCTKILVWHTRTEKPVLVNEGKKGFTDPSVEI

# Drug_Target_2_Reaction:
UDP-glucuronate + 3-beta-D-galactosyl-4-beta-D-galactosyl-O-beta-D-xylosylprotein = UDP + 3-beta-D-glucuronosyl-3-beta-D-galactosyl-4-beta-D-galactosyl-O- beta-D-xylosylprotein

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Involved in the biosynthesis of L2/HNK-1 carbohydrate epitope on glycoproteins. Can also play a role in glycosaminoglycan biosynthesis. Substrates include asialo- orosomucoid (ASOR), asialo-fetuin, and asialo-neural cell adhesion molecule. Requires sphingomyelin for activity:stearoyl- sphingomyelin was the most effective, followed by palmitoyl- sphingomyelin and lignoceroyl-sphingomyelin. Activity was demonstrated only for sphingomyelin with a saturated fatty acid and not for that with an unsaturated fatty acid, regardless of the length of the acyl group

# Drug_Target_2_SwissProt_ID:
Q9P2W7

# Drug_Target_2_SwissProt_Name:
B3GA1_HUMAN

# Drug_Target_2_Synonyms:
Beta-1,3-glucuronyltransferase 1
EC 2.4.1.135
GlcAT-P
GlcUAT-P
Glucuronosyltransferase-P
UDP-GlcUA:glycoprotein beta- 1,3-glucuronyltransferase

# Drug_Target_2_Theoretical_pI:
10.13

# Drug_Target_2_Transmembrane_Regions:
7-27

# Drug_Target_3_Cellular_Location:
Isoform 1:Cell membrane
single-pass type I membrane protein (Potential). Isoform 2:Secreted protein

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
TREM1

# Drug_Target_3_GenBank_ID_Gene:
AF196329

# Drug_Target_3_GenBank_ID_Protein:
8050527

# Drug_Target_3_GeneCard_ID:
TREM1

# Drug_Target_3_Gene_Name:
TREM1

# Drug_Target_3_Gene_Sequence:
>705 bp
ATGAGGAAGACCAGGCTCTGGGGGCTGCTGTGGATGCTCTTTGTCTCAGAACTCCGAGCT
GCAACTAAATTAACTGAGGAAAAGTATGAACTGAAAGAGGGGCAGACCCTGGATGTGAAA
TGTGACTACACGCTAGAGAAGTTTGCCAGCAGCCAGAAAGCTTGGCAGATAATAAGGGAC
GGAGAGATGCCCAAGACCCTGGCATGCACAGAGAGGCCTTCAAAGAATTCCCATCCAGTC
CAAGTGGGGAGGATCATACTAGAAGACTACCATGATCATGGTTTACTGCGCGTCCGAATG
GTCAACCTTCAAGTGGAAGATTCTGGACTGTATCAGTGTGTGATCTACCAGCCTCCCAAG
GAGCCTCACATGCTGTTCGATCGCATCCGCTTGGTGGTGACCAAGGGTTTTTCAGGGACC
CCTGGCTCCAATGAGAATTCTACCCAGAATGTGTATAAGATTCCTCCTACCACCACTAAG
GCCTTGTGCCCACTCTATACCAGCCCCAGAACTGTGACCCAAGCTCCACCCAAGTCAACT
GCCGATGTCTCCACTCCTGACTCTGAAATCAACCTTACAAATGTGACAGATATCATCAGG
GTTCCGGTGTTCAACATTGTCATTCTCCTGGCTGGTGGATTCCTGAGTAAGAGCCTGGTC
TTCTCTGTCCTGTTTGCTGTCACGCTGAGGTCATTTGTACCCTAG

# Drug_Target_3_General_Function:
Involved in immune triggering activity

# Drug_Target_3_General_References:
10799849	Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000 May 15;164(10):4991-5.
11922939	Gingras MC, Lapillonne H, Margolin JF: TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002 Mar;38(11):817-24.
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.

# Drug_Target_3_HGNC_ID:
HGNC:17760

# Drug_Target_3_HPRD_ID:
05472

# Drug_Target_3_ID:
2359

# Drug_Target_3_Locus:
6p21.1

# Drug_Target_3_Molecular_Weight:
26387

# Drug_Target_3_Name:
Triggering receptor expressed on myeloid cells 1

# Drug_Target_3_Number_of_Residues:
234

# Drug_Target_3_PDB_ID:
1SMO

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF07686	V-set

# Drug_Target_3_Protein_Sequence:
>Triggering receptor expressed on myeloid cells 1 precursor
MRKTRLWGLLWMLFVSELRAATKLTEEKYELKEGQTLDVKCDYTLEKFASSQKAWQIIRD
GEMPKTLACTERPSKNSHPVQVGRIILEDYHDHGLLRVRMVNLQVEDSGLYQCVIYQPPK
EPHMLFDRIRLVVTKGFSGTPGSNENSTQNVYKIPPTTTKALCPLYTSPRTVTQAPPKST
ADVSTPDSEINLTNVTDIIRVPVFNIVILLAGGFLSKSLVFSVLFAVTLRSFVP

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-20

# Drug_Target_3_Specific_Function:
Stimulates neutrophil and monocyte-mediated inflammatory responses. Triggers release of pro-inflammatory chemokines and cytokines, as well as increased surface expression of cell activation markers. Amplifier of inflammatory responses that are triggered by bacterial and fungal infections and is a crucial mediator of septic shock

# Drug_Target_3_SwissProt_ID:
Q9NP99

# Drug_Target_3_SwissProt_Name:
TREM1_HUMAN

# Drug_Target_3_Synonyms:
TREM-1
Triggering receptor expressed on monocytes 1
Triggering receptor expressed on myeloid cells 1 precursor

# Drug_Target_3_Theoretical_pI:
9.13

# Drug_Target_3_Transmembrane_Regions:
206-226

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
DDX6

# Drug_Target_4_GenBank_ID_Gene:
BC065007

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
DDX6

# Drug_Target_4_Gene_Sequence:
>1452 bp
ATGAGCACGGCCAGAACAGAGAACCCTGTTATAATGGGTCTGTCCAGTCAAAATGGTCAG
CTGAGAGGCCCTGTGAAACCCACTGGTGGCCCTGGAGGAGGGGGCACACAGACACAGCAA
CAGATGAACCAGCTGAAAAACACCAACACAATCAATAATGGCACTCAGCAGCAAGCACAG
AGTATGACCACCACTATTAAACCTGGTGATGACTGGAAAAAGACTTTAAAACTCCCTCCA
AAGGATCTAAGAATCAAAACTTCGGATGTGACCTCCACAAAAGGAAATGAGTTTGAAGAT
TACTGTTTGAAACGGGAGTTACTGATGGGAATTTTTGAAATGGGCTGGGAAAAGCCATCT
CCTATTCAGGAGGAGAGCATTCCCATTGCTTTATCTGGTAGGGATATCTTAGCTAGAGCA
AAAAATGGAACAGGCAAGAGCGGTGCCTACCTCATTCCCTTACTTGAACGGCTAGACCTG
AAGAAGGACAATATACAAGCAATGGTGATTGTTCCCACTAGAGAACTTGCTCTACAGGTC
AGTCAAATTTGCATCCAGGTCAGCAAACACATGGGAGGGGCCAAAGTGATGGCAACCACA
GGAGGAACCAATTTACGAGATGACATAATGAGGCTTGATGATACAGTGCACGTGGTGATT
GCTACCCCTGGGAGAATCCTGGATCTTATTAAGAAAGGAGTAGCAAAGGTTGATCATGTC
CAGATGATAGTATTGGATGAGGCAGATAAGTTGCTGTCACAGGATTTTGTGCAGATAATG
GAGGATATTATTCTCACGCTACCTAAAAACAGGCAGATTTTACTATATTCCGCTACTTTC
CCTCTTAGTGTACAGAAGTTCATGAATTCCCATTTGCAGAAACCCTATGAGATTAACCTG
ATGGAGGAACTAACTCTGAAGGGAGTAACCCAGTACTACGCATATGTAACTGAGCGCCAA
AAAGTACACTGCCTCAACACACTTTTCTCCAGGCTTCAGATAAACCAGTCGATCATTTTC
TGTAACTCCTCTCAGCGAGTTGAATTGCTAGCCAAGAAGATTTCTCAACTGGGTTATTCT
TGCTTCTATATTCATGCTAAAATGAGGCAGGAACATCGAAATCGTGTATTTCATGATTTC
CGAAATGGCTTATGCCGCAATCTTGTTTGCACTGATCTGTTTACCCGAGGTATTGATATA
CAAGCTGTGAATGTGGTAATAAACTTTGATTTCCCAAAGCTGGCAGAGACCTATCTCCAT
CGTATTGGAAGATCAGGTCGCTTTGGTCATCTTGGCTTAGCCATCAACTTGATCACATAT
GATGATCGCTTCAACCTGAAAAGTATTGAGGAGCAGCTGGGAACAGAAATTAAACCTATT
CCGAGCAACATTGATAAGAGCCTGTATGTGGCAGAATACCACAGCGAGCCTGTAGAAGAT
GAGAAACCTTAA

# Drug_Target_4_General_Function:
Involved in nucleic acid binding

# Drug_Target_4_General_References:
1394235	Akao Y, Seto M, Yamamoto K, Iida S, Nakazawa S, Inazawa J, Abe T, Takahashi T, Ueda R: The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. Cancer Res. 1992 Nov 1;52(21):6083-7.
1579499	Lu D, Yunis JJ: Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3. Nucleic Acids Res. 1992 Apr 25;20(8):1967-72.

# Drug_Target_4_HGNC_ID:
HGNC:2747

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
4288

# Drug_Target_4_Locus:
11q23.3

# Drug_Target_4_Molecular_Weight:
54418

# Drug_Target_4_Name:
Probable ATP-dependent RNA helicase DDX6

# Drug_Target_4_Number_of_Residues:
483

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00270	DEAD
PF00271	Helicase_C

# Drug_Target_4_Protein_Sequence:
>Probable ATP-dependent RNA helicase DDX6
MSTARTENPVIMGLSSQNGQLRGPVKPTGGPGGGGTQTQQQMNQLKNTNTINNGTQQQAQ
SMTTTIKPGDDWKKTLKLPPKDLRIKTSDVTSTKGNEFEDYCLKRELLMGIFEMGWEKPS
PIQEESIPIALSGRDILARAKNGTGKSGAYLIPLLERLDLKKDNIQAMVIVPTRELALQV
SQICIQVSKHMGGAKVMATTGGTNLRDDIMRLDDTVHVVIATPGRILDLIKKGVAKVDHV
QMIVLDEADKLLSQDFVQIMEDIILTLPKNRQILLYSATFPLSVQKFMNSHLQKPYEINL
MEELTLKGVTQYYAYVTERQKVHCLNTLFSRLQINQSIIFCNSSQRVELLAKKISQLGYS
CFYIHAKMRQEHRNRVFHDFRNGLCRNLVCTDLFTRGIDIQAVNVVINFDFPKLAETYLH
RIGRSGRFGHLGLAINLITYDDRFNLKSIEEQLGTEIKPIPSNIDKSLYVAEYHSEPVED
EKP

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
In the process of mRNA degradation, may play a role in mRNA decapping

# Drug_Target_4_SwissProt_ID:
P26196

# Drug_Target_4_SwissProt_Name:
DDX6_HUMAN

# Drug_Target_4_Synonyms:
ATP-dependent RNA helicase p54
DEAD box protein 6
EC 3.6.1.-
Oncogene RCK

# Drug_Target_4_Theoretical_pI:
8.93

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AE017222

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
TT_P0059

# Drug_Target_5_Gene_Sequence:
>1170 bp
ATGAAGCGCCTTTCCCTGAGGGAGGCCTGGCCCTACCTGAAAGACCTCCAGCAAGATCCC
CTCGCCGTCCTGCTGGCGTGGGGCCGGGCCCACCCCCGGCTCTTCCTTCCCCTGCCCCGC
TTCCCCCTGGCCCTGATCTTTGACCCCGAGGGGGTGGAGGGGGCGCTCCTCGCCGAGGGG
ACCACCAAGGCCACCTTCCAGTACCGGGCCCTCTCCCGCCTCACGGGGAGGGGCCTCCTC
ACCGACTGGGGGGAAAGCTGGAAGGAGGCGCGCAAGGCCCTCAAAGACCCCTTCCTGCCG
AAGAACGTCCGCGGCTACCGGGAGGCCATGGAGGAGGAGGCCCGGGCCTTCTTCGGGGAG
TGGCGGGGGGAGGAGCGGGACCTGGACCACGAGATGCTCGCCCTCTCCCTGCGCCTCCTC
GGGCGGGCCCTCTTCGGGAAGCCCCTCTCCCCAAGCCTCGCGGAGCACGCCCTTAAGGCC
CTGGACCGGATCATGGCCCAGACCAGGAGCCCCCTGGCCCTCCTGGACCTGGCCGCCGAA
GCCCGCTTCCGGAAGGACCGGGGGGCCCTCTACCGCGAGGCGGAAGCCCTCATCGTCCAC
CCGCCCCTCTCCCACCTTCCCCGAGAGCGCGCCCTGAGCGAGGCCGTGACCCTCCTGGTG
GCGGGCCACGAGACGGTGGCGAGCGCCCTCACCTGGTCCTTTCTCCTCCTCTCCCACCGC
CCGGACTGGCAGAAGCGGGTGGCCGAGAGCGAGGAGGCGGCCCTCGCCGCCTTCCAGGAG
GCCCTGAGGCTCTACCCCCCCGCCTGGATCCTCACCCGGAGGCTGGAAAGGCCCCTCCTC
CTGGGAGAGGACCGGCTCCCCCCGGGCACCACCCTGGTCCTCTCCCCCTACGTGACCCAG
AGGCTCCACTTCCCCGATGGGGAGGCCTTCCGGCCCGAGCGCTTCCTGGAGGAAAGGGGG
ACCCCTTCGGGGCGCTACTTCCCCTTTGGCCTGGGGCAGAGGCTCTGCCTGGGGCGGGAC
TTCGCCCTCCTCGAGGGCCCCATCGTCCTCAGGGCCTTCTTCCGCCGCTTCCGCCTAGAC
CCCCTCCCCTTCCCCCGGGTCCTCGCCCAGGTCACCCTGAGGCCCGAAGGCGGGCTTCCC
GCGCGGCCTAGGGAGGAGGTGCGGGCGTGA

# Drug_Target_5_General_Function:
Involved in monooxygenase activity

# Drug_Target_5_General_References:
12401810	Yano JK, Blasco F, Li H, Schmid RD, Henne A, Poulos TL: Preliminary characterization and crystal structure of a thermostable cytochrome P450 from Thermus thermophilus. J Biol Chem. 2003 Jan 3;278(1):608-16. Epub 2002 Oct 24.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4289

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
44257

# Drug_Target_5_Name:
Cytochrome P450

# Drug_Target_5_Number_of_Residues:
389

# Drug_Target_5_PDB_ID:
1N97

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_5_Protein_Sequence:
>Cytochrome P450
MKRLSLREAWPYLKDLQQDPLAVLLAWGRAHPRLFLPLPRFPLALIFDPEGVEGALLAEG
TTKATFQYRALSRLTGRGLLTDWGESWKEARKALKDPFLPKNVRGYREAMEEEARAFFGE
WRGEERDLDHEMLALSLRLLGRALFGKPLSPSLAEHALKALDRIMAQTRSPLALLDLAAE
ARFRKDRGALYREAEALIVHPPLSHLPRERALSEAVTLLVAGHETVASALTWSFLLLSHR
PDWQKRVAESEEAALAAFQEALRLYPPAWILTRRLERPLLLGEDRLPPGTTLVLSPYVTQ
RLHFPDGEAFRPERFLEERGTPSGRYFPFGLGQRLCLGRDFALLEGPIVLRAFFRRFRLD
PLPFPRVLAQVTLRPEGGLPARPREEVRA

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q746J6

# Drug_Target_5_SwissProt_Name:
Q746J6_THET2

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
10.17

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Nucleus (Potential)

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
HIF1AN

# Drug_Target_6_GenBank_ID_Gene:
AF395830

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
HIF1AN

# Drug_Target_6_Gene_Sequence:
>1050 bp
ATGGCGGCGACAGCGGCGGAGGCTGTGGCCTCTGGCTCTGGAGAGCCCCGGGAGGAGGCT
GGAGCCCTCGGCCCCGCCTGGGATGAATCCCAGTTGCGCAGTTATAGCTTCCCGACTAGG
CCCATTCCGCGTCTGAGTCAGAGCGACCCCCGGGCAGAGGAGCTTATTGAGAATGAGGAG
CCTGTGGTGCTGACCGACACAAATCTTGTGTATCCTGCCCTGAAATGGGACCTTGAATAC
CTGCAAGAGAATATTGGCAATGGAGACTTCTCTGTGTACAGTGCCAGCACCCACAAGTTC
TTGTACTATGATGAGAAGAAGATGGCCAATTTCCAGAACTTTAAGCCGAGGTCCAACAGG
GAAGAAATGAAATTTCATGAGTTCGTTGAGAAACTGCAGGATATACAGCAGCGAGGAGGG
GAAGAGAGGTTGTATCTGCAGCAAACGCTCAATGACACTGTGGGCAGGAAGATTGTCATG
GACTTCTTAGGTTTTAACTGGAACTGGATTAATAAGCAACAGGGAAAGCGTGGCTGGGGG
CAGCTTACCTCTAACCTGCTGCTCATTGGCATGGAAGGAAATGTGACACCTGCTCACTAT
GATGAGCAGCAGAACTTTTTTGCTCAGATAAAAGGTTACAAACGATGCATCTTATTCCCT
CCGGATCAGTTCGAGTGCCTCTACCCATACCCTGTTCATCACCCATGTGACAGACAGAGC
CAGGTGGACTTTGACAATCCCGACTACGAGAGGTTCCCTAATTTCCAAAATGTGGTTGGT
TACGAAACAGTGGTTGGCCCTGGTGATGTTCTTTACATCCCAATGTACTGGTGGCATCAC
ATAGAGTCATTACTAAATGGGGGGATTACCATCACTGTGAACTTCTGGTATAAGGGGGCT
CCCACCCCTAAGAGAATTGAATATCCTCTCAAAGCTCATCAGAAAGTGGCCATAATGAGA
AACATTGAGAAGATGCTTGGAGAGGCCTTGGGGAACCCACAAGAGGTGGGGCCCTTGTTG
AACACAATGATCAAGGGCCGATACAACTAG

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
11641274	Mahon PC, Hirota K, Semenza GL: FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001 Oct 15;15(20):2675-86.
12042299	Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ: Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem. 2002 Jul 19;277(29):26351-5. Epub 2002 May 31.
12080085	Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002 Jun 15;16(12):1466-71.
12432100	Dann CE 3rd, Bruick RK, Deisenhofer J: Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15351-6. Epub 2002 Nov 13.
12446723	Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW, Ratcliffe PJ, Schofield CJ: Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. J Biol Chem. 2003 Jan 17;278(3):1802-6. Epub 2002 Nov 21.

# Drug_Target_6_HGNC_ID:
HGNC:17113

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4290

# Drug_Target_6_Locus:
10q24

# Drug_Target_6_Molecular_Weight:
40286

# Drug_Target_6_Name:
Hypoxia-inducible factor 1 alpha inhibitor

# Drug_Target_6_Number_of_Residues:
349

# Drug_Target_6_PDB_ID:
1H2N

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
Not Available

# Drug_Target_6_Protein_Sequence:
>Hypoxia-inducible factor 1 alpha inhibitor
MAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEE
PVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNR
EEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWG
QLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQS
QVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGA
PTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Hydroxylates HIF-1 alpha at 'Asp-803' in the C-terminal transactivation domain (CAD). Functions as an oxygen sensor and, under normoxic conditions, the hydroxylation prevents interaction of HIF-1 with transcriptional coactivators including Cbp/p300- interacting transactivator. Involved in transcriptional repression through interaction with HIF1A, VHL and histone deacetylases

# Drug_Target_6_SwissProt_ID:
Q9NWT6

# Drug_Target_6_SwissProt_Name:
HIF1N_HUMAN

# Drug_Target_6_Synonyms:
EC 1.14.11.16
FIH-1
Factor inhibiting HIF-1
Hypoxia- inducible factor asparagine hydroxylase

# Drug_Target_6_Theoretical_pI:
5.28

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
BX842581

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
serA

# Drug_Target_7_Gene_Sequence:
>1587 bp
TCACGACAGATCGACAACCTCGAGCTTGTAGGCGTCCACCGCCGCCGCGATCGCCGTCCG
CACGTCGTCGGGCACGTCTTGGTCCAGCCGCAGCAGAATCGTCGCGCCCGGGCCTTCGGC
GTCTTCGGAGAGCTGCGCGGCCTGGATATTCACCCCGGCCGTCCCCAGCAACGTGCCGAT
CTTGCCCAGCGCTCCCGGCCGGTCGACGTAGTGGATGATCAGGTTGATCCCCTGGGCGCG
CAGATCAAAGTGGCGGCCGTTGATCTGCACGATCTTCTGCGACAGCTGTGGGCCATACAG
CGTGCCCGAGACGGTCACCACCGAACCGTCCGCGCCGACCGCGCGAACGTCGACGACGCT
GCGGTGGTTGGGGCTTTCCGAGGCCTTACAGATCTCGGCGGTGACGCCACGTTCGGCGGC
CAATGCCGGTGCGTTGACAAATGTCACCGCATCCTCGATCACCGCCGAGAACAGGCCGCG
CAGCGCCGAAAGGCGCAGCACCTCAACCTCTTCGGCGGCCAGCTCACCGCGCACCTGCAC
CGACAACGACACCGGCAGTTCGTCGGACAACACACCCGCCAGCACGCCGAGCTTACGCAC
CAGATCCAGCCAGGGCGCCACCTCCTCGTTGACCACTCCGCCGCCGACGTTGACCGCGTC
GGGCACGAATTCCCCTGCCAGGGCCAGCCGCACGCTCTCGGCGACGTCGGTGCCCGCCCG
GTCCTGCGCCTCCGCGGTGGACGCACCCAGATGCGGTGTGACCACCACCTGTGCCAGCTC
GAACAGCGGGCTGTCGGTGCACGGTTCGGTGGCGAACACGTCCAGACCGGCCGCCCGCAC
GTGGCCGCCGGTGATCGCGTCGGCCAGTGCCGCCTCGTCCACCAGGCCGCCGCGCGCGGC
GTTGACGATGATGACGCCCGGCTTGGTCTTCGCCAGCGCCTCCTTGTCGATCAGTCCCGC
CGTCTCCGGTGTTTTCGGTAGGTGCACCGAGATGAAATCGGCGCGGGCCAGCAGGTCGTC
CAGGGACAGCAGTTCGATGCCCAGCTGCGCCGCACGGGCCGGCGAAACGTACGGGTCATA
GGCGACGACGTAAGCGCCGAACGCAGCGATCCGCTGGGCGACCAACTGCCCGATGCGGCC
CAGACCCACCACGCCGACGGTTTTGCCGAAGATCTCGGTACCGGAAAACGACGAACGCTT
CCAGGTGTGCTCGCGCAGCGACGCGTCGGCCGCCGGAATCTGGCGTGAGGCGGCCAGCAG
CAGCGCCAGCGCATGCTCCGCGGCGCTGTGGATGTTCGACGTCGGGGCGTTGACCACCAG
CACGCCGCGGGCCGTCGCGGCGTCCACGTCGACGTTGTCCAGCCCGACGCCGGCGCGCGC
GACGATCTTGAGCTTGGGGGCGGCGGCCAGCACCTCGGCGTCAACCGTGGTGGCCGATCG
CACCAGCAGCGCGTCCGCTTCGGGCACCGCGGCCAGCAGCTTGTCTCGGTCCGGACCGTC
AACCCAGCGCACCTCGACCTGATCTCCCAAGGCGGCAACCGTTGATGGGGCAAGTTTGTC
GGCGATCAACACAACAGGCAGGCTCAC

# Drug_Target_7_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_7_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4291

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
54555

# Drug_Target_7_Name:
D-3-phosphoglycerate dehydrogenase

# Drug_Target_7_Number_of_Residues:
528

# Drug_Target_7_PDB_ID:
1YGY

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF01842	ACT
PF02826	2-Hacid_dh_C

# Drug_Target_7_Protein_Sequence:
>D-3-phosphoglycerate dehydrogenase
MSLPVVLIADKLAPSTVAALGDQVEVRWVDGPDRDKLLAAVPEADALLVRSATTVDAEVL
AAAPKLKIVARAGVGLDNVDVDAATARGVLVVNAPTSNIHSAAEHALALLLAASRQIPAA
DASLREHTWKRSSFSGTEIFGKTVGVVGLGRIGQLVAQRIAAFGAYVVAYDPYVSPARAA
QLGIELLSLDDLLARADFISVHLPKTPETAGLIDKEALAKTKPGVIIVNAARGGLVDEAA
LADAITGGHVRAAGLDVFATEPCTDSPLFELAQVVVTPHLGASTAEAQDRAGTDVAESVR
LALAGEFVPDAVNVGGGVVNEEVAPWLDLVRKLGVLAGVLSDELPVSLSVQVRGELAAEE
VEVLRLSALRGLFSAVIEDAVTFVNAPALAAERGVTAEICKASESPNHRSVVDVRAVGAD
GSVVTVSGTLYGPQLSQKIVQINGRHFDLRAQGINLIIHYVDRPGALGKIGTLLGTAGVN
IQAAQLSEDAEGPGATILLRLDQDVPDDVRTAIAAAVDAYKLEVVDLS

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
3-phospho-D-glycerate + NAD(+) = 3- phosphonooxypyruvate + NADH

# Drug_Target_7_SwissProt_ID:
P0A544

# Drug_Target_7_SwissProt_Name:
SERA_MYCTU

# Drug_Target_7_Synonyms:
EC 1.1.1.95
PGDH

# Drug_Target_7_Theoretical_pI:
4.56

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AE000511

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
lpxA

# Drug_Target_8_Gene_Sequence:
>813 bp
TTATTCCTCTTGTTTTTCTTCGCTAGAATATTCGCTTGACTTATACGCCACGCCCCTAGA
ACTCTCTAAAATAAAAGAGCAAATCTCTTTCACAAAAGGGTTATTGGCATGCTCTTCTAA
TTCTAATTTAGCGCTCTCTCTTAAAGAGGGGATAGGGCGGAACAATCTTTTATAAAGTGC
ATAAATAAAATCAATATCCTTACTCTCTAATAATTGGCGCATCCGGTGGCGGTTTAACCC
CCTAATAAAAGCGCGATTGCCCTCTACGGTGCAATAAGGCGGCACGTCTTTGCCTAAAGC
GCTCTTACCGGCTATCATGCACCCTTTAGCGATACGCACAAACTGATGGATCGCGGTAAG
ACCGCCGATATTGACATAATCGCCTATTTCAATATGACCTGCTAAAGTTACGCCATTAGC
CAAAATACAATGGCTTCCAATCACGCAATCATGAGCGACATGCACATAAGCCATGAGCAG
GTTTTTATCCCCAATAAGGGTTTTTTTAATCCCCCCTTCAGTGCCGGGATTTATCATGCA
AAATTCCCGAATAAGGTTGTCTTCTCCAATAATCAGTTCGCTGTATTCGCCCTTATATTT
TAAATCTTGAGGCTGTGTGCCTAGCACGGCAAAAGGGAAAATTTCGGTGTTTTTCCCAAC
GAAAGTATGCCCTTGTAAGGTTACATTGTTGTGGAGTTTCACGCCTTCATCTAGTTTGAC
GCCATCTCCAATCACGCAAAATTCCCCAATCTCTACGCCCTTATTAATCTCTGCTTTAGG
AGAGATGATGGCTGTTTTTGCAATCTTACTCAT

# Drug_Target_8_General_Function:
Involved in acyltransferase activity

# Drug_Target_8_General_References:
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4292

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
29856

# Drug_Target_8_Name:
Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase

# Drug_Target_8_Number_of_Residues:
270

# Drug_Target_8_PDB_ID:
1J2Z

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_8_Protein_Sequence:
>Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MSKIAKTAIISPKAEINKGVEIGEFCVIGDGVKLDEGVKLHNNVTLQGHTFVGKNTEIFP
FAVLGTQPQDLKYKGEYSELIIGEDNLIREFCMINPGTEGGIKKTLIGDKNLLMAYVHVA
HDCVIGSHCILANGVTLAGHIEIGDYVNIGGLTAIHQFVRIAKGCMIAGKSALGKDVPPY
CTVEGNRAFIRGLNRHRMRQLLESKDIDFIYALYKRLFRPIPSLRESAKLELEEHANNPF
VKEICSFILESSRGVAYKSSEYSSEEKQEE

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Involved in the biosynthesis of lipid A, a phosphorylated glycolipid that anchors the lipopolysaccharide to the outer membrane of the cell (By similarity)

# Drug_Target_8_SwissProt_ID:
O25927

# Drug_Target_8_SwissProt_Name:
LPXA_HELPY

# Drug_Target_8_Synonyms:
EC 2.3.1.129
UDP-N-acetylglucosamine acyltransferase

# Drug_Target_8_Theoretical_pI:
6.99

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
Not Available

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
ATP6V1C1

# Drug_Target_9_Gene_Sequence:
Not Available

# Drug_Target_9_General_Function:
Not Available

# Drug_Target_9_General_References:
Not Available

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
7035

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
Not Available

# Drug_Target_9_Name:
V-type proton ATPase subunit C 1

# Drug_Target_9_Number_of_Residues:
0

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
Not Available

# Drug_Target_9_Protein_Sequence:
Not Available

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
Not Available

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
P21283

# Drug_Target_9_SwissProt_Name:
VATC1_HUMAN

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
Not Available

# Drug_Target_9_Transmembrane_Regions:
Not Available

#END_DRUGCARD DB01694
